Muncy Columbia Financial Corporation Announces Second Quarter 2026 Earnings

MUNCY COLUMBIA FINANCIAL Corp (CCFN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 Press Release – For Immediate Release July 20, 2026 Muncy Columbia Financial Corporation Announces Second Quarter 2026 Earnings Bloomsburg, PA – Muncy Columbia Financial Corporation (“Corporation”) (OTCQX: CCFN), parent company of Journey

Original reporting
Published Jul 20, 2026, 3:36 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 20, 2026, 3:39 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$CCFN
Bullish
medium confidence
Mentioned
$CCFN
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$CCFNBullishMed
01

Why it matters

Key drivers include higher net interest income and NIM, a higher credit loss provision, and improved non-performing assets. Non-interest income rose, but realized AFS losses increased and dividends per share were lower year-over-year.

02

Market read

Provides quantified earnings and credit-quality updates that can influence near-term positioning in small-cap/OTC regional bank names.

03

What to watch

The article notes a prepayment of outstanding long-term FHLB borrowings and a stock split; traders should separate balance-sheet actions and one-time income effects from core earnings power.

Relevance 7/10Novelty 6/10Timing: after-hours SEC 8-K filing with Q2 2026 results

Background

This is an SEC Form 8-K Item 2.02 with an attached press release covering Muncy Columbia Financial’s unaudited Q2 2026 results.

Company-level read

Ticker impact

$CCFNBullishMedium confidence
Context

Muncy Columbia Financial reported Q2 2026 GAAP net income of $7.155M ($0.67/share) and a 4.37% fully-tax-equivalent NIM.

Expected impact

Likely modest positive bias for the next session, but magnitude may be limited given OTC listing and absence of guidance.

Evidence & confidence

The filing provides multiple quantified datapoints: net interest income up $1.961M YoY, NIM up to 4.37%, credit loss provision up but NPA ratio down to 0.53%, and equity/book value per share rising to $18.72.

Market effects

Adds another datapoint on small-bank net interest income resilience and credit quality trends.

Limited to regional banking sentiment in Pennsylvania-area markets.

Low; no cross-border or macro policy linkage beyond standard rate/credit sensitivity.

Counterpoint

Non-interest items were volatile, including realized AFS debt losses of $1.445M and reduced dividends, which could temper enthusiasm.

Key entities

  • Muncy Columbia Financial Corporation

    OTCQX-listed parent company of Journey Bank that reported Q2 2026 financial results and balance-sheet updates.

  • Journey Bank

    Operating bank subsidiary referenced as the source of banking activity and credit performance.

Related articles

$CCFNMed

Muncy Columbia Financial Corporation Announces Third Quarter 2026 Earnings

MUNCY COLUMBIA FINANCIAL Corp (CCFN) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Press Release – For Immediate Release October 19, 2026 Muncy Columbia Financial Corporation Announces Third Quarter 2026 Earnings Bloomsburg, PA – Muncy Columbia Financial Corporation (“Corporation”) (OTCQX: CCFN), parent company of Journey Bank (“Bank”), has release

$MRCYMed

Mercury Systems 3Q 2026: Revenue $253.15M, EPS $0.21 — 10-Q Summary

Mercury Systems reported 3Q 2026 revenue of $253.15M, up 12.4% YoY, and net income of $13.09M, reversing a prior-year loss. Growth in radar and electronic warfare applications drove results, while C4I revenue declined. Gross margin improved to 35.2% from 27.9%. The company expects to recognize 46% of its $1.193B remaining performance obligations as revenue in the next 12 months.

$SNWVMed

Sanuwave Announces Q3 FY2026 Financial Results

SANUWAVE Health, Inc. (SNWV) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Sanuwave Announces Q3 FY2026 Financial Results Q3 2026 revenues were $8.6 million, down 24% from $11.3 million in Q3 2025. Q3 2026 gross margin was 77.3%, versus 77.6% in Q3 2025. GAAP operating loss was $1.1 million for Q3 2026 versus operating income of $0.9 millio

$CPIXHighAI 8/10

CUMBERLAND PHARMACEUTICALS REPORTS Q3 2026 FINANCIAL RESULTS & COMPANY UPDATE

CUMBERLAND PHARMACEUTICALS INC (CPIX) filed an SEC Form 8-K — Results of Operations and Financial Condition. CUMBERLAND PHARMACEUTICALS REPORTS Q3 2026 FINANCIAL RESULTS & COMPANY UPDATE $100 million Strategic Transaction Closed Plans to Submit New Drug Application for Ifetroban in DMD Top-Line Results Announced for Systemic Sclerosis Trial NASHVILLE, Tenn. (Nov. 10, 2026) – Cumberland

$ATROHighAI 8/10

Astronics shares tumble on soft fourth quarter revenue outlook

Astronics (ATRO) reported Q3 earnings of $1.08 per share, beating estimates, with revenue up 28.5% YoY to $271.7M. However, shares fell 11% on Q4 revenue guidance of $255M-$275M, below expectations. The company maintained its full-year 2026 revenue guidance. Aerospace segment sales hit a record $245.5M, with strong demand in inflight entertainment and connectivity.